Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors. 

Biotechnology

Verseau Therapeutics

Verseau Therapeutics' headquarters in Bedford, MA, United States

Susan Low

Lou Vaickus

Tatiana Novobrantseva

Xiaochuan Zhou

Denise M.

Wen Chen

Daniel Anderson

Robert Langer

Zhenping Zhu

Jong Chang

Anna Turetsky

Seung Min Yang

The Board of Directors at Verseau Therapeutics provides strategic oversight, governance, and guidance to ensure the company achieves its mission of developing innovative cancer immunotherapies. They play a crucial role in making high-level decisions, setting long-term objectives, and ensuring regulatory compliance.

Board of Directors

The Leadership Team at Verseau Therapeutics drives the strategic vision and execution of innovative cancer immunotherapy initiatives. Comprising key executives such as the Vice President, Chief Development Officer, Chief Medical Officer, and Co-founder & Chief Scientific Officer, this team oversees research and development, clinical trial direction, and regulatory compliance, ensuring that cutting-edge therapies effectively target and reprogram the tumor microenvironment for optimized patient outcomes.

Leadership Team

Verseau Therapeutics

Org chart

Board & advisors

Teams

Board of Directors

Leadership Team

Offices

Verseau Therapeutics

Org chart

Board & advisors

Teams

Board of Directors

Leadership Team

Offices

Related companies